Skip to main content

Fostera PRRS (Canada)

This treatment applies to the following species:
Company: Zoetis

Porcine Reproductive & Respiratory Syndrome Vaccine

Reproductive & Respiratory Forms

Modified Live Virus

For Whole Herd Protection

This product has been shown to be effective for the vaccination of healthy swine 1 day of age or older in PRRS virus-positive herds against respiratory and reproductive disease caused by PRRS virus. Duration of immunity of at least 19 weeks has been demonstrated against reproductive disease and at least 26 weeks against respiratory disease. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Efficacy has not been demonstrated in seropositive piglets. Safety of this product has been demonstrated when sows or gilts are vaccinated prior to breeding or at any stage of pregnancy. Protection against reproductive disease, however, was demonstrated when animals are vaccinated 6 weeks prior to breeding.

Directions For Use

Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Shake well and aseptically administer a single 2-mL dose intramuscularly. The presence of maternal antibody is known to interfere with the development of active immunity in young pigs and additional boosters will be required in most young animals. Consult your veterinarian for appropriate use and timing of vaccination.

Precautions

Do not vaccinate boars of breeding age. Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first reconstituted. Inactivate unused contents before disposal. Do not vaccinate within 21 days before slaughter. Fetal health risks associated with vaccination of pregnant animals with modified live vaccines cannot be unequivocally determined by clinical trials conducted for licensure. Management strategies based on vaccination of pregnant animals with modified live vaccines should be discussed with a veterinarian. Contains gentamicin as preservative. In case of anaphylaxis, administer epinephrine. Do not mix with other products, except as specified above. In case of human exposure, contact a physician.

Shedding and transmission of vaccine virus by vaccinates: Vaccine virus may be shed and transmitted to other populations of swine in direct or indirect contact with vaccinated swine. The duration of potential vaccine virus transmission may vary. Nonvaccinated pigs in contact with Fostera PRRS-vaccinated pigs may seroconvert to vaccine virus. Use of the vaccine in herds intended to remain PRRS virus seronegative is contraindicated. Introduction of vaccinated pigs into herds intended to remain PRRS virus seronegative is contraindicated.

For veterinary use only

Technical inquiries should be directed to Zoetis Canada Inc. Veterinary Services, (800) 461-0917.

VLN 190/PCN 19T1.20

Zoetis Inc., Kalamazoo, MI 49007, USA

January 2024

50-dose vial of vaccine

Rehydrate to 100 mL

100-mL vial of sterile diluent

40043177

CPN: 1198453.5

ZOETIS CANADA INC.
16,740 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9H 4M7
Order Desk:   800-663-8888
Technical Services Canada:   800-461-0917
Technical Services USA:   800-366-5288
Website:   www.zoetis.ca
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.

Animalytix

Copyright © 2024 Animalytix LLC. Updated: 2024-11-27